Seroconversions, Resistance, Adverse Events and Drug Adherence Among Subjects Taking Truvada for PrEP: A Nested Case Control Study
Phase of Trial: Phase IV
Latest Information Update: 05 Apr 2019
Price : $35 *
At a glance
- Drugs Emtricitabine/tenofovir disoproxil fumarate (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- Sponsors Gilead Sciences
- 05 Feb 2019 Planned End Date changed from 1 Apr 2020 to 1 Dec 2021.
- 05 Feb 2019 Planned primary completion date changed from 1 Apr 2020 to 1 Dec 2020.
- 31 Aug 2018 Biomarkers information updated